| LTX-Credence Corporation F3Q10 (Qtr End 04/30/2010) Earnings Call Transcript LTX-Credence Corporation (LTXC)F3Q10 Earnings Call May 26, 2010 10:00 am ETComplete Story » seekingalpha.com |
Investors Are Shunning Biotech and Big Pharma Firms Despite Renewed Growth Prospects Chad Brand submits: It was not too long ago that leading biotechnology companies fetched premium multiples to their large-cap pharmaceutical competitors. As the large, well-known pharma companies face many patent expirations in coming years, smaller and more growth-oriented biotech firms commanded both higher valuations and more favorable outlooks among investors. However, for some reason in recent months we have seen biotech stocks give up much of that premium. For the first time I can recall, many biotechs trade for below-market prices, in-line with slower growth pharmaceutical counterparts. Here is a summary of some leading large cap stocks in both the biotechnology and pharmaceutical areas. You can see that the P/E ratios are very similar but the projected growth rates are meaningfully higher for the biotech sector, by a factor of nearly 5x. The only conclusion I can draw from this is that biotech stocks continue to deserve higher relative valuations, but for some reason Wall Street has lost sight of this recently. (Click to enlarge)Complete Story » seekingalpha.com |
Kendall Law Group Investigates Enzo Biochem Inc. for Shareholders (Business Wire) DALLAS----Kendall Law Group, a national securities firm led by a former federal judge Joe Kendall with attorneys that include a former U.S. Attorney, is investigating Enzo Biochem Inc. for shareholders. us.rd.yahoo.com |
Clarient to Present at Two Investor Conferences in September [PR Newswire] - Clarient, Inc. , a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the biopharmaceutical industry, today announced that the Company is scheduled to make investor presentations at two investor conferences in the month of September. us.rd.yahoo.com |
Neil L. Lerner Joins Psychemedics Corporation as Top Financial Officer [PR Newswire] - Psychemedics Corporation today announced that Neil L. Lerner has joined the company as Vice President, Controller. Â us.rd.yahoo.com |